Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7


Digital Technologies and Adherence in Respiratory Diseases: The Road Ahead.

Blakey JD, Bender BG, Dima AL, Weinman J, Safioti G, Costello RW.

Eur Respir J. 2018 Nov 8. pii: 1801147. doi: 10.1183/13993003.01147-2018. [Epub ahead of print] Review.


Comparison of correct technique and preference for Spiromax®, Easyhaler® and Turbuhaler®: a single-site, single-visit, crossover study in inhaler-naïve adult volunteers.

Rönmark P, Jagorstrand B, Safioti G, Menon S, Bjermer L.

Eur Clin Respir J. 2018 Oct 22;5(1):1529536. doi: 10.1080/20018525.2018.1529536. eCollection 2018.


Evaluation of inhaler technique and achievement and maintenance of mastery of budesonide/formoterol Spiromax® compared with budesonide/formoterol Turbuhaler® in adult patients with asthma: the Easy Low Instruction Over Time (ELIOT) study.

Price DB, Thomas V, Richard Dekhuijzen PN, Bosnic-Anticevich S, Roche N, Lavorini F, Raju P, Freeman D, Nicholls C, Small IR, Sims E, Safioti G, Canvin J, Chrystyn H.

BMC Pulm Med. 2018 Jun 28;18(1):107. doi: 10.1186/s12890-018-0665-x.


Expert Nordic perspectives on the potential of novel inhalers to overcome unmet needs in the management of obstructive lung disease.

Løkke A, Ahlbeck L, Bjermer L, Mortensen J, Østrem A, Pasternack I, Safioti G, Torvinen S.

Eur Clin Respir J. 2015 Dec 16;2:29445. doi: 10.3402/ecrj.v2.29445. eCollection 2015.


Updated Medication Costs From A Real-Life Cost-Effectiveness Evaluation Of Budesonide/Formoterol Maintenance And Reliever Therapy In Asthma Maintenance And Reliever Therapy In Asthma.

Medin E, Safioti G, Lindqvist F, Torvinen S.

Value Health. 2015 Nov;18(7):A500. doi: 10.1016/j.jval.2015.09.1413. Epub 2015 Oct 20. No abstract available.


Effect of inhalation profile and throat geometry on predicted lung deposition of budesonide and formoterol (BF) in COPD: An in-vitro comparison of Spiromax with Turbuhaler.

Chrystyn H, Safioti G, Keegstra JR, Gopalan G.

Int J Pharm. 2015 Aug 1;491(1-2):268-76. doi: 10.1016/j.ijpharm.2015.05.076. Epub 2015 Jun 1.


The Potential Societal Cost Benefits of Improved Inhalation Technique With Duoresp® Spiromax® (Budesonide + Formoterol Fumarate Dihydrate) Compared With Symbicort® Turbuhaler® for the Management of Asthma and Chronic Obstructive Pulmonary Disease in Sweden.

Lewis A, Blackney M, Torvinen S, Lindqvist F, Safioti G, Grundström J, Polyzoi M, Plich A.

Value Health. 2014 Nov;17(7):A598-9. doi: 10.1016/j.jval.2014.08.2070. Epub 2014 Oct 26. No abstract available.

Supplemental Content

Loading ...
Support Center